Financial News

Recent Quotes
My Watchlist
Indicators
Motherlode Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Aimmune Therap (NQ: AIMT )

34.49 USD UNCHANGED
Last Price Updated: 7:11 PM EDT, Oct 12, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Aimmune Therap

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
AIMT Crosses Above Key Moving Average Level
In trading on Tuesday, shares of Aimmune Therapeutics Inc (AIMT) crossed above their 200 day moving average of $21.71, changing hands as high as $21.94 per share. Aimmune Therapeutics Inc shares are... 
Tags Stocks
From Market News Video
Jim Cramer Shares His Thoughts On Vail Resorts, Waste Management And More
On CNBC's "Mad Money Lightning Round,"Jim Cramer said he would buy some Vail Resorts, Inc. (NYSE: MTN) now and he ... 
Tags CNBC Benzinga CRK
From Benzinga
Aimmune Therapeu Bullish Moving Average Crossover Alert (AIMT)
Aimmune Therapeu (NASDAQ:AIMT) shares have crossed bullishly above their 10-day moving average of $20.03 on a volume of 217K shares. This may provide swing traders with an opportunity for... 
From Comtex SmarTrend® News Briefs
3 Biotech Stocks That Could Soar This Week
Investors better get ready for a busy week ahead. 
Tags MRNA Market News AIMT
From Motley Fool
The Week Ahead In Biotech: Conference Presentations, IPO News Flow Take The Spotlight
The holiday-shortened week saw a few huge moves by individual stocks. Abeona Therapeutics Inc (NASDAQ: ABEO) was among the biggest ... 
Tags AZN Top Stories Market News
From Benzinga
Notable Tuesday Option Activity: URI, AIMT, DCI
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in United Rentals Inc (URI), where a total of 6,310 contracts have traded so far, representing... 
Tags Stocks
From Market News Video
Attention Biotech Investors: Mark Your Calendar For These September PDUFA Dates
FDA activity remained brisk in August. The FDA gave its nod for a majority of drugs that came up for review, although Vanda ... 
Tags News Benzinga Top Stories
From Benzinga
The Daily Biotech Pulse: Ra Medical Earns Milestone, Aimmune Doses Patient In Egg Allergy Trial, Cara In-Licenses Platform
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ... 
Tags NVTR BASI CPRX
From Benzinga
Interesting AIMT Put And Call Options For October 18th
Investors in Aimmune Therapeutics Inc (AIMT) saw new options become available this week, for the October 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the... 
Tags Stocks
From Market News Video
Analysts Predict 36% Gains Ahead For The Holdings of IBB
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
3 Top Biotech Stocks to Buy in August
In the high-risk world of biotech investing, there are no guarantees of success. Still, sometimes investors can find places where the odds look reasonable enough to consider buying shares. 
Tags Market News IQV LGND
From Motley Fool
Aimmune Therapeu Shares Down -0.5% Since SmarTrend's Sell Call (AIMT)
SmarTrend identified a Downtrend for Aimmune Therapeu (NASDAQ:AIMT) on March 20th, 2019 at $21.45. In approximately 5 months, Aimmune Therapeu has returned 0.51% as of today's recent price of... 
From Comtex SmarTrend® News Briefs
Noteworthy Tuesday Option Activity: FIVE, AIMT, REV
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Five Below Inc (FIVE), where a total volume of 11,729 contracts has been traded... 
Tags Stocks
From Market News Video
Aimmune Therapeutics, Inc. (AIMT) Q2 2019 Earnings Call Transcript
AIMT earnings call for the period ending June 30, 2019. 
Tags Market News AIMT
From Motley Fool
DBV Resubmits Regulatory Application For Peanut Allergy Drug, Stock Rallies
Shares of small-cap biopharma company DBV TECHNOLOGIE/S ADR (NASDAQ: DBVT) wereadvancing strongly Thursday in reaction to an ... 
Tags General Trading Ideas Benzinga
From Benzinga
The Math Shows XBI Can Go To $128
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
The Daily Biotech Pulse: Hookipa Leaps, Illumina Dims On Q2 Warning, Novartis-Amgen Halt Alzheimer's Study
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting ... 
Tags Biotech IRMD AMGN
From Benzinga
55 Biggest Movers From Yesterday
Gainers Revolution Lighting Technologies Inc (NASDAQ: RVLT) shares surged 132.9% to close at $0.58 on Thursday after the company ... 
Tags AXGT AIMT SLP
From Benzinga
Here's Why Aimmune Therapeutics Fell 7% Today
The Institute for Clinical and Economic Review questions the short-term risks of the biotech's drug. 
Tags Market News DBVT AIMT
From Motley Fool
48 Stocks Moving In Thursday's Mid-Day Session
Gainers Revolution Lighting Technologies Inc (NASDAQ: RVLT) shares climbed 185.1% to $0.71 after the company was granted an ... 
Tags CODX AMRS Mid/Day Gainers
From Benzinga
Thursday's ETF Movers: IHF, IBB
In trading on Thursday, the iShares US Healthcare Providers ETF is outperforming other ETFs, up about 3.2% on the day. Components of that ETF showing particular strength include shares of Cigna, up... 
Tags ETFs
From ETF Channel
Aimmune Therapeu Falling Today on Above-Average Volume (AIMT)
Shares of Aimmune Therapeu are trading today in above average volume, with the share price falling 8.5% to $18.19. About 627,000 shares have been traded today, as compared to... 
From Comtex SmarTrend® News Briefs
Aimmune Therapeu: New 52-Week Low Set Today (AIMT)
Shares of Aimmune Therapeu (NASDAQ:AIMT) traded today at $18.67, breaking its 52-week low. So far today approximately 285,000 shares have been exchanged, as compared to an average 30-day volume... 
From Comtex SmarTrend® News Briefs
Aimmune Therapeu Crosses Below its 10-day MA (AIMT)
Aimmune Therapeu (NASDAQ:AIMT) crossed under its 10-day moving average of $20.72 on a volume of 214K shares. Swing traders may find an opportunity for a short position, as such... 
From Comtex SmarTrend® News Briefs
First Week of AIMT August 16th Options Trading
Investors in Aimmune Therapeutics Inc (AIMT) saw new options become available this week, for the August 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AIMT... 
Tags Stocks
From Market News Video
Surprising Analyst 12-Month Target For UBIO
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
First Week of July 19th Options Trading For Aimmune Therapeutics (AIMT)
Investors in Aimmune Therapeutics Inc (AIMT) saw new options begin trading this week, for the July 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AIMT... 
Tags Stocks
From Market News Video
Top 5 New Drug Launches of 2019 -- and the Biotech Stocks That Could Win Big
These drugs and the biotechs that make them could be on the way to tremendous success in the near future. 
Tags ABBV Market News AIMT
From Motley Fool
Aimmune Therapeutics, Inc. (AIMT) Q1 2019 Earnings Call Transcript
AIMT earnings call for the period ending March 31, 2019. 
Tags AIMT Market News
From Motley Fool
Aimmune Therapeutics, Inc. (AIMT) Q1 2019 Earnings Call Transcript
AIMT earnings call for the period ending March 31, 2019. 
Tags fbn/markets fox/business/markets fbn
From FOX Business
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback